Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine

Kunhwa Kim; Alexandre Bazinet; Sanam Loghavi; Marina Konopleva; Kapil Bhalla; Naval Daver; Joseph D. Khoury; Tapan Kadia; Nathaniel R. Wilson; Jonathan L. Curry; Meghan Heberton; Darla Miller; Sherry Pierce; Gautam Borthakur; Naveen Pemmaraju

doi:10.1016/j.leukres.2022.106884

Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine

Kunhwa Kim, Alexandre Bazinet, Sanam Loghavi, Marina Konopleva, Kapil Bhalla, Naval Daver, Joseph D. Khoury, Tapan Kadia, Nathaniel R. Wilson, Jonathan L. Curry, Meghan Heberton, Darla Miller, Sherry Pierce, Gautam Borthakur, Naveen Pemmaraju

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	106884
Journal	Leukemia Research
Volume	119
DOIs	https://doi.org/10.1016/j.leukres.2022.106884
State	Published - Aug 2022
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2022.106884

Cite this

Kim, K., Bazinet, A., Loghavi, S., Konopleva, M., Bhalla, K., Daver, N., Khoury, J. D., Kadia, T., Wilson, N. R., Curry, J. L., Heberton, M., Miller, D., Pierce, S., Borthakur, G., & Pemmaraju, N. (2022). Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine. Leukemia Research, 119, [106884]. https://doi.org/10.1016/j.leukres.2022.106884

Kim, K, Bazinet, A, Loghavi, S, Konopleva, M, Bhalla, K, Daver, N, Khoury, JD, Kadia, T, Wilson, NR, Curry, JL, Heberton, M, Miller, D, Pierce, S, Borthakur, G & Pemmaraju, N 2022, 'Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine', Leukemia Research, vol. 119, 106884. https://doi.org/10.1016/j.leukres.2022.106884

@article{72d08db5c1b3491f9093216cd8bde779,

title = "Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine",

author = "Kunhwa Kim and Alexandre Bazinet and Sanam Loghavi and Marina Konopleva and Kapil Bhalla and Naval Daver and Khoury, {Joseph D.} and Tapan Kadia and Wilson, {Nathaniel R.} and Curry, {Jonathan L.} and Meghan Heberton and Darla Miller and Sherry Pierce and Gautam Borthakur and Naveen Pemmaraju",

note = "Funding Information: This study was supported in part by the MDACC Support Grant P30 CA016672 from the National Cancer Institute. Funding Information: MK: Ablynx: Other: grant support, Research Funding; Agios: Other: grant support, Research Funding; Ascentage: Other: grant support, Research Funding; Calithera: Other: grant support, Research Funding; AstraZeneca: Other: grant support, Research Funding; Forty Seven: Other: grant support, Research Funding; Cellectis: Other: grant support; F. Hoffmann-La Roche: Consultancy, Honoraria, Other: grant support; Rafael Pharmaceuticals: Other: grant support, Research Funding; AbbVie: Consultancy, Honoraria, Other: Grant Support, Research Funding; Eli Lilly: Patents & Royalties: intellectual property rights, Research Funding; Genentech: Consultancy, Honoraria, Other: grant support, Research Funding; Stemline Therapeutics: Research Funding; Sanofi: Other: grant support, Research Funding; Reata Pharmaceuticals: Current holder of stock options in a privately-held company, Patents & Royalties: intellectual property rights; Novartis: Other: research funding pending, Patents & Royalties: intellectual property rights; KisoJi: Research Funding. ",

year = "2022",

month = aug,

doi = "10.1016/j.leukres.2022.106884",

language = "English (US)",

volume = "119",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine

AU - Kim, Kunhwa

AU - Bazinet, Alexandre

AU - Loghavi, Sanam

AU - Konopleva, Marina

AU - Bhalla, Kapil

AU - Daver, Naval

AU - Khoury, Joseph D.

AU - Kadia, Tapan

AU - Wilson, Nathaniel R.

AU - Curry, Jonathan L.

AU - Heberton, Meghan

AU - Miller, Darla

AU - Pierce, Sherry

AU - Borthakur, Gautam

AU - Pemmaraju, Naveen

N1 - Funding Information: This study was supported in part by the MDACC Support Grant P30 CA016672 from the National Cancer Institute. Funding Information: MK: Ablynx: Other: grant support, Research Funding; Agios: Other: grant support, Research Funding; Ascentage: Other: grant support, Research Funding; Calithera: Other: grant support, Research Funding; AstraZeneca: Other: grant support, Research Funding; Forty Seven: Other: grant support, Research Funding; Cellectis: Other: grant support; F. Hoffmann-La Roche: Consultancy, Honoraria, Other: grant support; Rafael Pharmaceuticals: Other: grant support, Research Funding; AbbVie: Consultancy, Honoraria, Other: Grant Support, Research Funding; Eli Lilly: Patents & Royalties: intellectual property rights, Research Funding; Genentech: Consultancy, Honoraria, Other: grant support, Research Funding; Stemline Therapeutics: Research Funding; Sanofi: Other: grant support, Research Funding; Reata Pharmaceuticals: Current holder of stock options in a privately-held company, Patents & Royalties: intellectual property rights; Novartis: Other: research funding pending, Patents & Royalties: intellectual property rights; KisoJi: Research Funding.

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85131735210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131735210&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2022.106884

DO - 10.1016/j.leukres.2022.106884

M3 - Letter

C2 - 35691130

AN - SCOPUS:85131735210

SN - 0145-2126

VL - 119

JO - Leukemia Research

JF - Leukemia Research

M1 - 106884

ER -

Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this